Human sex-determination and disorders of sex-development (DSD)

Area of Science:

• Genetics
• Developmental Biology
• Endocrinology

Background:

• Human errors of sex determination, known as disorders of sex development (DSD), involve complex genetic pathways.
• Recent research has identified novel genes and signaling pathways implicated in DSD, including SOX, GATA4, FOG2, and MAP kinase signaling.
• Mutations in NR5A1 are recognized causes of both male spermatogenic failure and female ovarian insufficiency.

Purpose of the Study:

• To critically review the genetic basis of human sex determination.
• To examine the evidence linking specific gene mutations, with a focus on MAP3K1, to non-syndromic 46,XY gonadal dysgenesis and XX testicular/ovotesticular DSD.
• To highlight differences between human and mouse models of sex determination.

Main Methods:

• Literature review of recent genetic studies on DSD.
• Analysis of gene mutations associated with virilization in 46,XX individuals and gonadal dysgenesis in 46,XY individuals.
• Focus on mutations in key genes such as MAP3K1, NR5A1, SOX, GATA4, and FOG2.

Main Results:

• Mutations in SOX family genes, GATA4, FOG2, and MAP kinase signaling genes are associated with specific DSD phenotypes.
• NR5A1 gene mutations are significant contributors to both male infertility and female reproductive insufficiency.
• MAP3K1 mutations are increasingly recognized in non-syndromic 46,XY gonadal dysgenesis and XX testicular/ovotesticular DSD.

Conclusions:

• Genetic factors play a crucial role in human sex determination, and disruptions lead to DSD.
• MAP3K1 is a key gene implicated in specific forms of DSD, particularly 46,XY gonadal dysgenesis.
• Understanding these genetic pathways provides critical insights into human development and disease, underscoring species-specific differences in sex determination.